Copyright Reports & Markets. All rights reserved.

Global Tianeptine Sales Market Report 2021

Request for Sample of this report
Buy now

1 Tianeptine Market Overview

  • 1.1 Tianeptine Product Scope
  • 1.2 Tianeptine Segment by Type
    • 1.2.1 Global Tianeptine Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Patent
    • 1.2.3 Generic
  • 1.3 Tianeptine Segment by Application
    • 1.3.1 Global Tianeptine Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Depression and Anxiety
    • 1.3.3 Irritable Bowel Syndrome
  • 1.4 Tianeptine Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Tianeptine Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Tianeptine Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Tianeptine Price Trends (2016-2027)

2 Tianeptine Estimates and Forecasts by Region

  • 2.1 Global Tianeptine Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Tianeptine Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Tianeptine Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Tianeptine Revenue Market Share by Region (2016-2021)
  • 2.3 Global Tianeptine Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Tianeptine Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Tianeptine Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Tianeptine Estimates and Projections (2016-2027)
    • 2.4.2 Europe Tianeptine Estimates and Projections (2016-2027)
    • 2.4.3 China Tianeptine Estimates and Projections (2016-2027)
    • 2.4.4 Japan Tianeptine Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Tianeptine Estimates and Projections (2016-2027)
    • 2.4.6 India Tianeptine Estimates and Projections (2016-2027)

3 Global Tianeptine Competition Landscape by Players

  • 3.1 Global Top Tianeptine Players by Sales (2016-2021)
  • 3.2 Global Top Tianeptine Players by Revenue (2016-2021)
  • 3.3 Global Tianeptine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tianeptine as of 2020)
  • 3.4 Global Tianeptine Average Price by Company (2016-2021)
  • 3.5 Manufacturers Tianeptine Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Tianeptine Market Size by Type

  • 4.1 Global Tianeptine Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Tianeptine Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Tianeptine Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Tianeptine Price by Type (2016-2021)
  • 4.2 Global Tianeptine Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Tianeptine Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Tianeptine Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Tianeptine Price Forecast by Type (2022-2027)

5 Global Tianeptine Market Size by Application

  • 5.1 Global Tianeptine Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Tianeptine Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Tianeptine Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Tianeptine Price by Application (2016-2021)
  • 5.2 Global Tianeptine Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Tianeptine Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Tianeptine Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Tianeptine Price Forecast by Application (2022-2027)

6 North America Tianeptine Market Facts & Figures

  • 6.1 North America Tianeptine Sales by Company
    • 6.1.1 North America Tianeptine Sales by Company (2016-2021)
    • 6.1.2 North America Tianeptine Revenue by Company (2016-2021)
  • 6.2 North America Tianeptine Sales Breakdown by Type
    • 6.2.1 North America Tianeptine Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Tianeptine Sales Breakdown by Type (2022-2027)
  • 6.3 North America Tianeptine Sales Breakdown by Application
    • 6.3.1 North America Tianeptine Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Tianeptine Sales Breakdown by Application (2022-2027)

7 Europe Tianeptine Market Facts & Figures

  • 7.1 Europe Tianeptine Sales by Company
    • 7.1.1 Europe Tianeptine Sales by Company (2016-2021)
    • 7.1.2 Europe Tianeptine Revenue by Company (2016-2021)
  • 7.2 Europe Tianeptine Sales Breakdown by Type
    • 7.2.1 Europe Tianeptine Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Tianeptine Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Tianeptine Sales Breakdown by Application
    • 7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)

8 China Tianeptine Market Facts & Figures

  • 8.1 China Tianeptine Sales by Company
    • 8.1.1 China Tianeptine Sales by Company (2016-2021)
    • 8.1.2 China Tianeptine Revenue by Company (2016-2021)
  • 8.2 China Tianeptine Sales Breakdown by Type
    • 8.2.1 China Tianeptine Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Tianeptine Sales Breakdown by Type (2022-2027)
  • 8.3 China Tianeptine Sales Breakdown by Application
    • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Tianeptine Market Facts & Figures

  • 9.1 Japan Tianeptine Sales by Company
    • 9.1.1 Japan Tianeptine Sales by Company (2016-2021)
    • 9.1.2 Japan Tianeptine Revenue by Company (2016-2021)
  • 9.2 Japan Tianeptine Sales Breakdown by Type
    • 9.2.1 Japan Tianeptine Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Tianeptine Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Tianeptine Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Tianeptine Market Facts & Figures

  • 10.1 Southeast Asia Tianeptine Sales by Company
    • 10.1.1 Southeast Asia Tianeptine Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Tianeptine Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Tianeptine Sales Breakdown by Type
    • 10.2.1 Southeast Asia Tianeptine Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Tianeptine Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Tianeptine Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Tianeptine Market Facts & Figures

  • 11.1 India Tianeptine Sales by Company
    • 11.1.1 India Tianeptine Sales by Company (2016-2021)
    • 11.1.2 India Tianeptine Revenue by Company (2016-2021)
  • 11.2 India Tianeptine Sales Breakdown by Type
    • 11.2.1 India Tianeptine Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Tianeptine Sales Breakdown by Type (2022-2027)
  • 11.3 India Tianeptine Sales Breakdown by Application
    • 11.3.1 India Tianeptine Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Tianeptine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Tianeptine Business

  • 12.1 Servier
    • 12.1.1 Servier Corporation Information
    • 12.1.2 Servier Business Overview
    • 12.1.3 Servier Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Servier Tianeptine Products Offered
    • 12.1.5 Servier Recent Development
  • 12.2 Lupin Limited
    • 12.2.1 Lupin Limited Corporation Information
    • 12.2.2 Lupin Limited Business Overview
    • 12.2.3 Lupin Limited Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Lupin Limited Tianeptine Products Offered
    • 12.2.5 Lupin Limited Recent Development
  • 12.3 PharmaS
    • 12.3.1 PharmaS Corporation Information
    • 12.3.2 PharmaS Business Overview
    • 12.3.3 PharmaS Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 PharmaS Tianeptine Products Offered
    • 12.3.5 PharmaS Recent Development
  • 12.4 Antibiotice
    • 12.4.1 Antibiotice Corporation Information
    • 12.4.2 Antibiotice Business Overview
    • 12.4.3 Antibiotice Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Antibiotice Tianeptine Products Offered
    • 12.4.5 Antibiotice Recent Development
  • 12.5 Serdia Pharmaceuticals
    • 12.5.1 Serdia Pharmaceuticals Corporation Information
    • 12.5.2 Serdia Pharmaceuticals Business Overview
    • 12.5.3 Serdia Pharmaceuticals Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Serdia Pharmaceuticals Tianeptine Products Offered
    • 12.5.5 Serdia Pharmaceuticals Recent Development
  • 12.6 Alvogen
    • 12.6.1 Alvogen Corporation Information
    • 12.6.2 Alvogen Business Overview
    • 12.6.3 Alvogen Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Alvogen Tianeptine Products Offered
    • 12.6.5 Alvogen Recent Development
  • 12.7 Bausch Health
    • 12.7.1 Bausch Health Corporation Information
    • 12.7.2 Bausch Health Business Overview
    • 12.7.3 Bausch Health Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Bausch Health Tianeptine Products Offered
    • 12.7.5 Bausch Health Recent Development
  • 12.8 Genefar B.V.
    • 12.8.1 Genefar B.V. Corporation Information
    • 12.8.2 Genefar B.V. Business Overview
    • 12.8.3 Genefar B.V. Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Genefar B.V. Tianeptine Products Offered
    • 12.8.5 Genefar B.V. Recent Development
  • 12.9 Arena Pharmaceuticals
    • 12.9.1 Arena Pharmaceuticals Corporation Information
    • 12.9.2 Arena Pharmaceuticals Business Overview
    • 12.9.3 Arena Pharmaceuticals Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Arena Pharmaceuticals Tianeptine Products Offered
    • 12.9.5 Arena Pharmaceuticals Recent Development
  • 12.10 Glenmark
    • 12.10.1 Glenmark Corporation Information
    • 12.10.2 Glenmark Business Overview
    • 12.10.3 Glenmark Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Glenmark Tianeptine Products Offered
    • 12.10.5 Glenmark Recent Development
  • 12.11 Novartis
    • 12.11.1 Novartis Corporation Information
    • 12.11.2 Novartis Business Overview
    • 12.11.3 Novartis Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Novartis Tianeptine Products Offered
    • 12.11.5 Novartis Recent Development
  • 12.12 Dongwha Pharm
    • 12.12.1 Dongwha Pharm Corporation Information
    • 12.12.2 Dongwha Pharm Business Overview
    • 12.12.3 Dongwha Pharm Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Dongwha Pharm Tianeptine Products Offered
    • 12.12.5 Dongwha Pharm Recent Development
  • 12.13 Liconsa SA
    • 12.13.1 Liconsa SA Corporation Information
    • 12.13.2 Liconsa SA Business Overview
    • 12.13.3 Liconsa SA Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Liconsa SA Tianeptine Products Offered
    • 12.13.5 Liconsa SA Recent Development
  • 12.14 Mylan
    • 12.14.1 Mylan Corporation Information
    • 12.14.2 Mylan Business Overview
    • 12.14.3 Mylan Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Mylan Tianeptine Products Offered
    • 12.14.5 Mylan Recent Development
  • 12.15 Adamed
    • 12.15.1 Adamed Corporation Information
    • 12.15.2 Adamed Business Overview
    • 12.15.3 Adamed Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Adamed Tianeptine Products Offered
    • 12.15.5 Adamed Recent Development
  • 12.16 Neuraxpharm Arzneimittel
    • 12.16.1 Neuraxpharm Arzneimittel Corporation Information
    • 12.16.2 Neuraxpharm Arzneimittel Business Overview
    • 12.16.3 Neuraxpharm Arzneimittel Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Neuraxpharm Arzneimittel Tianeptine Products Offered
    • 12.16.5 Neuraxpharm Arzneimittel Recent Development
  • 12.17 Grupo Insud
    • 12.17.1 Grupo Insud Corporation Information
    • 12.17.2 Grupo Insud Business Overview
    • 12.17.3 Grupo Insud Tianeptine Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Grupo Insud Tianeptine Products Offered
    • 12.17.5 Grupo Insud Recent Development

13 Tianeptine Manufacturing Cost Analysis

  • 13.1 Tianeptine Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Tianeptine
  • 13.4 Tianeptine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Tianeptine Distributors List
  • 14.3 Tianeptine Customers

15 Market Dynamics

  • 15.1 Tianeptine Market Trends
  • 15.2 Tianeptine Drivers
  • 15.3 Tianeptine Market Challenges
  • 15.4 Tianeptine Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Tianeptine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tianeptine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Patent
    Generic

    Segment by Application
    Depression and Anxiety
    Irritable Bowel Syndrome

    The Tianeptine market is analysed and market size information is provided by regions (countries). Segment by Application, the Tianeptine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Servier
    Lupin Limited
    PharmaS
    Antibiotice
    Serdia Pharmaceuticals
    Alvogen
    Bausch Health
    Genefar B.V.
    Arena Pharmaceuticals
    Glenmark
    Novartis
    Dongwha Pharm
    Liconsa SA
    Mylan
    Adamed
    Neuraxpharm Arzneimittel
    Grupo Insud

    Buy now